L2 Diagnostics LLC
Woodbridge, CT
- UEI
- GKA7VH5LFR25
- CAGE
- 43BA5
- SAM.gov registration
- Active through
Company facts
- Self-certified in SAM.gov
- Entity structure
- Corporate Entity (Not Tax Exempt)
- NAICS codes registered in SAM.gov
- SAM.gov registration date
- Physical address
- 37 Seymour Rd, Woodbridge, CT 06525, USA
Registration and certifications come from SAM.gov and the SBA; company details from public web sources. Updated .
Recent federal awards
| Award | Agency | Obligated | Awarded |
|---|---|---|---|
| A viral vector-based vaccine to induce humoral and cellular immune protection against powassan virus in a tick… | National Institute of Allergy and Infectious Diseases | $281,786 | |
| A vaccine targeting mosquito metabolic pathways to eradicate malaria - abstract the world health organization,… | National Institute of Allergy and Infectious Diseases | $599,709 | |
| A point of care test for babesia microti - abstract babesia microti is a parasite that is transmitted to humans by the… | National Institute of Allergy and Infectious Diseases | $567,852 | |
| Pfag, a multivalent peptide vaccine against malaria - abstract pfag is our novel malaria vaccine, composed of short… | National Institute of Allergy and Infectious Diseases | $599,954 | |
| Therapeutic vaccine platform to boost immune responses in tuberculosis | National Institute of Allergy and Infectious Diseases | $599,471 |
About L2 Diagnostics LLC
L2 Diagnostics LLC is a for-profit limited liability company based in Woodbridge, Connecticut, specializing in biomedical research and the development of diagnostics, therapeutics, and vaccines for infectious diseases. The company focuses on innovative medical interventions, particularly targeting complex infectious diseases such as malaria, Chikungunya virus, Lyme disease, and tick-borne pathogens. As a small business registered in SAM.gov, L2 Diagnostics LLC provides advanced research and development services to federal agencies, with a strong emphasis on cutting-edge vaccine and diagnostic technologies.
Through federal contract awards, L2 Diagnostics LLC has primarily engaged in Small Business Innovation Research (SBIR) Program Phase I contracts with the National Institute of Allergy and Infectious Diseases (NIAID). These contracts have included a $599,471 award for developing a therapeutic vaccine platform to boost immune responses in tuberculosis and a $300,000 contract for discovering and validating novel diagnostic biomarkers for malaria. The contracts are designated as total small business set-asides, highlighting the company's role in supporting innovative research by smaller scientific enterprises. While the vendor has not received numerous prime federal contract awards, its SBIR contracts demonstrate a focused approach to developing specialized medical research solutions.
L2 Diagnostics LLC has been substantially more active in federal grant awards, securing multiple project grants from NIAID under the Allergy and Infectious Diseases Research Federal Grant Program. These grants cover a diverse range of infectious disease research, including developing a mosquito-targeted vaccine to disrupt malaria transmission, creating a viral vector-based vaccine against Powassan virus, designing a point-of-care diagnostic test for Babesia microti infection, and exploring multivalent peptide vaccines against malaria. The company has also received grants for innovative research on Chikungunya virus, Lyme arthritis, and tick-borne pathogen transmission prevention. These grants, typically ranging from $281,786 to $299,954, demonstrate L2 Diagnostics LLC's comprehensive approach to addressing complex infectious disease challenges through advanced scientific research and novel technological interventions.
SBA capabilities narrative
Biotechnology R&D, Medical Diagnosotics R&D, Pharmaceutical R&D
Quick answers
What is L2 Diagnostics LLC's UEI?
L2 Diagnostics LLC's Unique Entity ID (UEI) in SAM.gov is GKA7VH5LFR25.
What is L2 Diagnostics LLC's CAGE code?
L2 Diagnostics LLC's CAGE code is 43BA5.
What is L2 Diagnostics LLC's primary NAICS code?
L2 Diagnostics LLC's primary NAICS code is 541714 (Research and Development in Biotechnology (except Nanobiotechnology)).
Where is L2 Diagnostics LLC located?
L2 Diagnostics LLC's physical address in SAM.gov is 37 Seymour Rd, Woodbridge, CT 06525, USA.
Is L2 Diagnostics LLC registered in SAM.gov?
Yes. L2 Diagnostics LLC's SAM.gov registration is active through January 22, 2027.
What is L2 Diagnostics LLC's most recent federal award?
L2 Diagnostics LLC's most recent federal grant award is A viral vector-based vaccine to induce humoral and cellular immune protection against powassan virus in a tick… (R41AI188982), from National Institute of Allergy and Infectious Diseases, on September 23, 2025.
On GovTribe
See L2 Diagnostics LLC's full federal record
- Federal contract awards
- Federal grant awards
- Funding analysis by agency, NAICS and set-aside
- Similar vendors